Abstract: Aqueous formulations of indacaterol are disclosed. The formulations may find use in the treatment of respiratory disorders, inflammatory disorders, or obstructive airway diseases. Methods of using the formulations and kits comprising the formulations are also encompassed by the disclosure.

Abstract: Aqueous formulations of indacaterol are disclosed. The formulations may find use in the treatment of respiratory disorders, inflammatory disorders, or obstructive airway diseases. Methods of using the formulations and kits comprising the formulations are also encompassed by the disclosure.

Abstract: There is provided a mesh for use in forming droplets of liquid in a nebuliser, the mesh comprising a first portion (22) made of a first material having a plurality of holes passing therethrough; and a second portion (26) made of a second material that is in contact with the first portion (22), the second portion (26) having a corresponding plurality of holes passing therethrough, the plurality of holes in the second portion forming nozzles (28) for an outlet side of the mesh; wherein the first material has a higher density than the second material.

Abstract: Aqueous formulations of indacaterol are disclosed. The formulations may find use in the treatment of respiratory disorders, inflammatory disorders, or obstructive airway diseases. Methods of using the formulations and kits comprising the formulations are also encompassed by the disclosure.

Abstract: The present invention relates to a feedback for inhalation. In order to further improve feedback and instructions to further support the correct use of an inhaler, a feedback apparatus (10) for inhalation is provided that comprises an inhaler interface (11), a processor (14), a feedback device (16), and a feature assigner (13). The inhaler interface is configured to temporarily attach the feedback apparatus to an inhalation apparatus. The feedback device is configured to provide a feedback to the user to aid in inhalation with the inhalation apparatus. The feature assigner is configured to identify a type of a predetermined feature of the attached inhalation apparatus, and the feedback device is configured to provide the feedback in dependency of the identified type of feature to instruct the user to adjust inhalation maneuver adapted to the attached inhalation apparatus.

Abstract: The present invention relates to a system for monitoring asthma symptoms of a subject (12), comprising a monitoring unit (14) configured to monitor at least one objective asthma symptom of the subject, an analysis unit (16) configured to determine an asthma status of the subject based on the at least one objective asthma symptom monitored by the monitoring unit, a test unit (18) configured to provide a test for collecting subjective asthma symptoms from the subject, if the at least one objective asthma symptom monitored by the monitoring unit (14) has changed in a manner that the change reveals a deterioration of the asthma status of the subject. Further the system comprises a calibration unit (24) configured to calibrate the at least one objective asthma symptom gathered from the subject with respect to a calibration test, wherein the calibration unit (24) is arranged to perform calibration at least once during an initial phase of use of the system (10).

Abstract: The present invention relates to a feedback for inhalation. In order to further improve feedback and instructions to further support the correct use of an inhaler, a feedback apparatus (10) for inhalation is provided that comprises an inhaler interface (11), a processor (14), a feedback device (16), and a feature assigner (13). The inhaler interface is configured to temporarily attach the feedback apparatus to an inhalation apparatus. The feedback device is configured to provide a feedback to the user to aid in inhalation with the inhalation apparatus. The feature assigner is configured to identify a type of a predetermined feature of the attached inhalation apparatus, and the feedback device is configured to provide the feedback in dependency of the identified type of feature to instruct the user to adjust inhalation maneuver adapted to the attached inhalation apparatus.

Abstract: There is provided a mesh for use in forming droplets of liquid in a nebuliser, the mesh comprising a first portion (22) made of a first material having a plurality of holes passing therethrough; and a second portion (26) made of a second material that is in contact with the first portion (22), the second portion (26) having a corresponding plurality of holes passing therethrough, the plurality of holes in the second portion forming nozzles (28) for an outlet side of the mesh; wherein the first material has a higher density than the second material.

Abstract: Elongated drug, especially salbutamol sulphate, and/or carrier particles, especially lactose, pharmaceutical compositions comprising the same, and use of the elongated particles in the manufacture of a medicament for the treatment of respiratory disease.

Abstract: A dry powder inhaler (10) consists of a chamber (12) into which powder is introduced from a metering system, and a mouthpiece (26) through which a patient inhales, connected by a duct (16), so that air flows through the chamber carrying the powder into the patient's lungs. Within the duct is an impactor (25) consisting of a plate (27) spaced in front of a similarly sized aperture, and between the chamber and the impactor plate is an orifice (18) narrower than the duct, so the air stream is diverted along S-shaped paths to avoid the plate. The presence of the impactor can improve the efficiency of delivery of a drug to the lungs, and decrease the unwanted dose to the mouth and throat, as the latter is principally due to agglomerates or larger particles which are intercepted or broken up by the impactor.